Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	72.86	-25.10	-92.49
Graham Fair Price	-12.71	62.34	71.41
PEG	58.97	-0.02	0.01
Price/Book	-3.11	1.41	1.45
Price/Cash Flow	-15.15	4.16	4.90
Prices/Earnings	36.75	3.23	-2.36
Price/Sales	-90.54	5.33	56.37
Price/FCF	-15.15	4.16	4.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2514.34	0.91	0.03
Operating Margin	1862.66	0.39	-0.02
ROA	-38.55	< 0.005	< 0.005
ROE	-0.15	0.11	-29.15
ROIC	< 0.005	0.06	19571.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	0.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.00	210.28	20864.12
EPS QOQ	-1.99	1.71	-13.97
FCF QOQ	4.73	0.19	-96.01
Revenue QOQ	-0.89	9.66	983.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-53331.34	0.00	inf
Days Sales Outstanding (DSO)	43.70	2.64	-93.97
Inventory Turnover	< 0.005	0.00	inf
Debt/Capitalization	0.22	0.22	-3.23
Quick Ratio	-0.78	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38.39	39.81	3.71
Cash	141.46	298.85	111.25
Capex	-0.18	-0.06	67.17
Free Cash Flow	11.38	13.48	18.42
Revenue	0.99	10.51	962.19
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	-0.81	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-182.54	-38.67	78.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating